Literature DB >> 15163873

Nitric oxide in preterm infant with pulmonary hypoplasia.

Nandkishor S Kabra1, Martin R Kluckow, Jane Powell.   

Abstract

Premature infants with hypoplastic lungs may have elevated pulmonary vascular resistance with right to left shunt across ductus arteriosus and/or foramen ovale. Inhaled nitric oxide (NO) being selective pulmonary vasodilator without significant effects on systemic circulation can potentially reverse this shunt. The authors herewith report a case of a premature infant with severe hypoxemic respiratory failure after preterm premature prolonged rupture of membranes leading to oligohydramnios and pulmonary hypoplasia that was treated successfully with NO and describe the neurodevelopmental outcome at 1 year of age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163873     DOI: 10.1007/bf02725633

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  7 in total

Review 1.  Intrapartum and delivery room management of premature rupture of membranes complicated by oligohydramnios.

Authors:  H W Kilbride; J D Yeast; D W Thibeault
Journal:  Clin Perinatol       Date:  1989-12       Impact factor: 3.430

2.  Inhaled nitric oxide for oligohydramnios-induced pulmonary hypoplasia: a report of two cases and review of the literature.

Authors:  Cara Geary; Jeffrey Whitsett
Journal:  J Perinatol       Date:  2002-01       Impact factor: 2.521

3.  Neonatal pulmonary hypoplasia and perinatal mortality in patients with midtrimester rupture of amniotic membranes--a critical analysis.

Authors:  H N Winn; M Chen; E Amon; T L Leet; J B Shumway; D Mostello
Journal:  Am J Obstet Gynecol       Date:  2000-06       Impact factor: 8.661

Review 4.  Inhaled nitric oxide for respiratory failure in preterm infants.

Authors:  K J Barrington; N N Finer
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 5.  Nitric oxide for respiratory failure in infants born at or near term.

Authors:  N N Finer; K J Barrington
Journal:  Cochrane Database Syst Rev       Date:  2001

6.  Inhaled nitric oxide for premature infants after prolonged rupture of the membranes.

Authors:  A Peliowski; N N Finer; P C Etches; A J Tierney; C A Ryan
Journal:  J Pediatr       Date:  1995-03       Impact factor: 4.406

7.  Neonatal pulmonary manifestations due to prolonged amniotic leak.

Authors:  V K Bhutani; S Abbasi; S Weiner
Journal:  Am J Perinatol       Date:  1986-07       Impact factor: 1.862

  7 in total
  8 in total

1.  Inhaled nitric oxide in preterm infants with prolonged preterm rupture of the membranes: a case series.

Authors:  J Semberova; S M O'Donnell; J Franta; J Miletin
Journal:  J Perinatol       Date:  2015-04       Impact factor: 2.521

2.  Decreased OLA1 (Obg-Like ATPase-1) Expression Drives Ubiquitin-Proteasome Pathways to Downregulate Mitochondrial SOD2 (Superoxide Dismutase) in Persistent Pulmonary Hypertension of the Newborn.

Authors:  Adam Schultz; Olubunmi A Olorundami; Ru-Jeng Teng; Jason Jarzembowski; Zheng-Zheng Shi; Suresh N Kumar; Kirkwood Pritchard; Girija G Konduri; Adeleye J Afolayan
Journal:  Hypertension       Date:  2019-09-03       Impact factor: 10.190

Review 3.  Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management.

Authors:  Enrique M Ostrea; Esterlita T Villanueva-Uy; Girija Natarajan; Herbert G Uy
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Association of Early Inhaled Nitric Oxide With the Survival of Preterm Neonates With Pulmonary Hypoplasia.

Authors:  Kevin R Ellsworth; Marc A Ellsworth; Amy L Weaver; Kristin C Mara; Reese H Clark; William A Carey
Journal:  JAMA Pediatr       Date:  2018-07-02       Impact factor: 16.193

Review 5.  Diagnostic Approach to Pulmonary Hypertension in Premature Neonates.

Authors:  Vasantha H S Kumar
Journal:  Children (Basel)       Date:  2017-08-24

Review 6.  The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns?

Authors:  Frederico Vieira; Marjorie Makoni; Edgardo Szyld; Krishnamurthy Sekar
Journal:  Front Pediatr       Date:  2021-03-31       Impact factor: 3.418

7.  Factors influencing decision making in neonatology: inhaled nitric oxide in preterm infants.

Authors:  Veena Manja; Gordon Guyatt; Satyan Lakshminrusimha; Susan Jack; Haresh Kirpalani; John A F Zupancic; Dmitry Dukhovny; John J You; Sandra Monteiro
Journal:  J Perinatol       Date:  2018-10-23       Impact factor: 2.521

8.  Inhaled nitric oxide for preterm premature rupture of membranes, oligohydramnios, and pulmonary hypoplasia.

Authors:  Valerie Y Chock; Krisa P Van Meurs; Susan R Hintz; Richard A Ehrenkranz; James A Lemons; Douglas E Kendrick; David K Stevenson
Journal:  Am J Perinatol       Date:  2008-12-09       Impact factor: 1.862

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.